Chapter: Pharmaceutical Biotechnology: Fundamentals and Applications - Oligonucleotides

| Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail |

Oligonucleotides

Oligonucleotides (ONs) are (short) chains of (chemi-cally modified) ribo- or deoxyribonucleotides.

Oligonucleotides

INTRODUCTION

Oligonucleotides (ONs) are (short) chains of (chemically modified) ribo- or deoxyribonucleotides. Their ability to bind to chromosomal DNA or mRNA through Watson–Crick and Hoogsteen base-pairing offers possibilities for highly specific intervention in gene transcription, translation, repair, and recombination for therapeutic applications. In theory, a sequence of 15 to 17 bases occurs only once in the human genome, which would allow specific manipulation of single genes for ONs beyond this size range. In addition, therapeutic effects of ONs can be obtained through sequence-specific binding of transcription factors and intramolecular folding into complex three-dimensional structures that can bind to and interfere with the function of biomolecules. Finally, cells display specific receptors for ONs with associated immunological responses that can be of therapeutic value.

Due to this multitude of possible effects of nucleic acids, ONs can be very potent molecules, yet interpretation of the mechanism of therapeutic action of a specific oligonucleotide sequence is not straight-forward (Stein et al., 2005). Apart from the desired activity, ONs are inclined to display (sequence-specific) unintended effects. Partial sequence homol-ogy may affect expression of genes other than the targeted gene (known as off-target effects), immune responses may be induced, and binding to proteins and peptides can alter their activity.

sOther characteristics of ONs also impede clear-cut application as therapeutics. Their physicochemical characteristics induce rapid uptake by macrophages and excretion by the kidneys hindering target tissue accumulation. In addition, spontaneous passage over cell membranes for intracellular applications is difficult. Finally, ONs are sensitive to the action of nucleases leading to their degradation. Over the years a number of different modifications have been developed that overcome (part of) these problems (Fig. 1) (Kurreck, 2003). Many of the clinically studied ONs contain one or more of these modified nucleotides.





Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail


Copyright © 2018-2020 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.